Abstract:Background: "Dysbiosis" in the gut microbiome has been implicated in auto-immune diseases, in inflammatory diseases, in some cancers and mental disorders. The challenge is to unravel the cellular and molecular basis of dysbiosis so as to understand the disease manifestation. Main body: Next generation sequencing and genome enabled technologies have led to the establishment of the composition of gut microbiomes and established that "dysbiosis" is the cause of several diseases. In a few cases the cellular and molecular changes accompanying dysbiosis have been investigated and correlated with the disease. Gut microbiome studies have indicated that Christensenella minuta controls obesity in mice, Faecalibacterium prausnitzii protects mice against intestinal inflammation and Akkermansia muciniphila reverses obesity and insulin resistance by secreting endocannabinoids. In mice polysaccharide antigen A on the surface of Bacteroides fragilis, reduces inflammation. Such experiments provide the link between the gut microbiome and human health but implicating dysbiosis with extra-intestinal diseases like arthritis, muscular dystrophy, vaginosis, fibromyalgia, some cancers and mental disorders appears to be more challenging. The relevance of gut microbiome to the eye appears to be very remote. But considering that the eye is the site of inflammatory diseases like uveitis, scleritis, Mooren's corneal ulcer etc. it is possible that these diseases are also influenced by dysbiosis. In mice signals from the gut microbiota activate retina specific T cells that are involved in autoimmune uveitis. Such information would open up new strategies for therapy where the emphasis would be on restoring the diversity in the gut by antibiotic or specific drug use, specific microbe introduction, probiotic use and fecal transplant therapy. The ocular surface microbiome may also be responsible for eye diseases in man but such studies are lacking. Microbiome of the healthy cornea and conjunctiva have been identified. But whether the ocular microbiome exhibits dysbiosis with disease? Whether ocular microbiome is influenced by the gut microbiome? What mediates the cross-talk between the gut and ocular microbiomes? These are questions that need to be addressed to understand idiopathic infections of the eye. Conclusions: Evaluating diseases remote from the gut would unfold the mysteries of the microbiome.

The gut microbiome and HLA-B27-associated anterior uveitis: a case-control study

Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis

Investigation of the acute pathogenesis of spondyloarthritis/HLA-B27-associated anterior uveitis based on genome-wide association analysis and single-cell transcriptomics

Putative Pathobionts in HLA-B27-Associated Spondyloarthropathy

We are not alone: a case for the human microbiome in extra intestinal diseases

Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site

Single Cell Sequencing Suggests Mucosal Origins of T Cells in HLA-B27-associated Inflammation

Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis

Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients

Association of gut microbiota with spontaneous autoimmune uveitis studied by human flora reconstitution of germ-free mice

Microbiome and Autoimmune Uveitis

Genome-wide association study of anterior uveitis

Regulation of Autoimmunity by the Microbiome

Gut Microbial Alterations Associated With Protection From Autoimmune Uveitis

Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection

Choroidal and retinal vascular changes in HLA-B27-associated anterior uveitis

Gut microbiota and autoimmune neurologic disorders: a two-sample bidirectional Mendelian randomization study

Bugs & us: the role of the gut in autoimmunity

Gut microbiota as a source of signals that trigger spontaneous ocular autoimmunity.

HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity

Gut microbiota as a sensor of autoimmune response and treatment for rheumatoid arthritis